Most of these insulins have been designed for use in adults. However, a new short-acting insulin has been approved for use in children—Humalog Junior KwikPen.
What is Humalog prescribed for?
Humalog is indicated for the treatment of diabetes type 1 and diabetes type 2. Humalog Junior KwikPen is specifically indicated for use in children, who require smaller doses of insulin compared to adults.
What’s unique about the Humalog Junior KwikPen?
The Humalog Junior Kiwkpen can dose in half unit increments. This precise dosing is a benefit for children with diabetes who require smaller doses of insulin.
The Junior Kwikpen is also prefilled, and disposable so you can toss it when you’re done.
We've sent a link to download the GoodRx mobile app to your phone.
We were unable to send a link to your phone.
Can I share my KwikPen?
No. All Humalog products should not be shared even if a new needle is used.
The main difference is the number of units a patient can receive. The Humalog KwikPen can give up to 60 units per injection whereas the Humalog Junior KwikPen can only give up to 30 units per injection.
Both the Humalog and Humalog Junior KwikPens are the same strength which is 100 units per mL. Each Humalog Junior KwikPen contains 300 units of insulin.
Do any other short-acting insulins have a ‘Junior’ product?
Sort of. Novolog has the NovoPen Echo, a device that allows for half-unit dosings. Novolog used to make a NovoPen Junior, however, it was discontinued in March of 2013 and replaced by the NovoPen Echo.